Genetic variants for breast cancer risk assessment
US8951735B2 · kind B2 · utility
3Cited by
13References
53Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jul 3, 2009 |
| Grant date | Feb 10, 2015 |
| Priority date | — |
| Expiry date | Apr 7, 2031 |
Classification
- Technology area (CPC Y)Emerging Cross-Sectional Technologies
- CPC primaryY02A90/10
- WIPO fieldBiotechnology
- WIPO sectorChemistry
Abstract
The invention pertains to certain genetic variants that have been determined to be susceptibility variants of breast cancer. Methods of disease management, including diagnosing increased susceptibility to breast cancer, methods of predicting response to therapy and methods of predicting prognosis using such variants are described. The invention further relates to kits useful in the methods of the invention.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.